Gottlich, Harrison C.
Gregory, Adriana V.
Sharma, Vidit
Khanna, Abhinav
Moustafa, Amr U.
Lohse, Christine M.
Potretzke, Theodora A.
Korfiatis, Panagiotis
Potretzke, Aaron M.
Denic, Aleksandar
Rule, Andrew D.
Takahashi, Naoki
Erickson, Bradley J.
Leibovich, Bradley C.
Kline, Timothy L. http://orcid.org/0000-0002-7917-9853
Funding for this research was provided by:
Mayo Clinic Ventures, nference, and the Mayo Clinic Office of Translation to Practice
National Institute of Diabetes and Digestive and Kidney Diseases (K01DK110136, R03DK125632)
Article History
Received: 11 September 2022
Revised: 28 February 2023
Accepted: 1 March 2023
First Online: 17 March 2023
Declarations
:
: The following statement was supplied by the Mayo Clinic IRB. “The Committee discussed the investigator’s justification for waiver of consent and waiver of HIPAA authorization as provided in the IRBe application (sections “Waiver of Informed Consent” and “HIPAA Authorization Waiver”) and approved waiver of consent in accordance with 45CFR46.116 and waiver of HIPAA authorization in accordance with applicable HIPAA regulations.”
: The authors declare no competing interests.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of Mayo Clinic or nference or the National Institutes of Health.